|
1
|
Kahn SE: Clinical review 135: The
importance of beta-cell failure in the development and progression
of type 2 diabetes. J Clin Endocrinol Metab. 86:4047–4058. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ding Y, Sun X and Shan PF: MicroRNAs and
cardiovascular disease in diabetes mellitus. Biomed Res Int.
2017:40803642017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Quan A, Pan Y, Singh KK, Polemidiotis J,
Teoh H, Leong-Poi H and Verma S: Cardiovascular inflammation is
reduced with methotrexate in diabetes. Mol Cell Biochem.
432:159–167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vamos EP, Millett C, Parsons C, Aylin P,
Majeed A and Bottle A: Nationwide study on trends in hospital
admissions for major cardiovascular events and procedures among
people with and without diabetes in England, 2004–2009. Diabetes
Care. 35:265–272. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nichols GA, Hillier TA, Erbey JR and Brown
JB: Congestive heart failure in type 2 diabetes: Prevalence,
incidence, and risk factors. Diabetes Care. 24:1614–1619. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li SL, Reddy MA, Cai Q, Meng L, Yuan H,
Lanting L and Natarajan R: Enhanced proatherogenic responses in
macrophages and vascular smooth muscle cells derived from diabetic
db/db mice. Diabetes. 55:2611–2619. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Doran AC, Meller N and McNamara CA: Role
of smooth muscle cells in the initiation and early progression of
atherosclerosis. Arterioscler Thromb Vasc Biol. 28:812–819. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gomez D and Owens GK: Smooth muscle cell
phenotypic switching in atherosclerosis. Cardiovasc Res.
95:156–164. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wall VZ and Bornfeldt KE: Arterial smooth
muscle. Arterioscler Thromb Vasc Biol. 34:2175–2179. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu WY, Yan H, Wang XB, Gui YZ, Gao F, Tang
XL, Qin YL, Su M, Chen T and Wang YP: Sodium tanshinone IIA silate
inhibits high glucose-induced vascular smooth muscle cell
proliferation and migration through activation of AMP-activated
protein kinase. PLoS One. 9:e949572014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi L, Ji Y, Jiang X, Zhou L, Xu Y, Li Y,
Jiang W, Meng P and Liu X: Liraglutide attenuates high
glucose-induced abnormal cell migration, proliferation, and
apoptosis of vascular smooth muscle cells by activating the GLP-1
receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.
Cardiovasc Diabetol. 14:182015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Natarajan R and Nadler JL: Lipid
inflammatory mediators in diabetic vascular disease. Arterioscler
Thromb Vasc Biol. 24:1542–1548. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu H, Kong L, Zhou S, Cui W, Xu F, Luo M,
Li X, Tan Y and Miao L: The role of microRNAs in diabetic
nephropathy. J Diabetes Res. 2014:9201342014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alexander MR and Owens GK: Epigenetic
control of smooth muscle cell differentiation and phenotypic
switching in vascular development and disease. Annu Rev Physiol.
74:13–40. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maegdefessel L, Rayner KJ and Leeper NJ:
MicroRNA regulation of vascular smooth muscle function and
phenotype: Early career committee contribution. Arterioscler Thromb
Vasc Biol. 35:2–6. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Davis-Dusenbery BN, Chan MC, Reno KE,
Weisman AS, Layne MD, Lagna G and Hata A: Down-regulation of
Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for
modulation of vascular smooth muscle cell phenotype by transforming
growth factor-beta and bone morphogenetic protein 4. J Biol Chem.
286:28097–28110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang RN, Zheng B, Li LM, Zhang J, Zhang
XH and Wen JK: Tongxinluo inhibits vascular inflammation and
neointimal hyperplasia through blockade of the positive feedback
loop between miR-155 and TNF-alpha. Am J Physiol Heart Circ
Physiol. 307:H552–H562. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun SG, Zheng B, Han M, Fang XM, Li HX,
Miao SB, Su M, Han Y, Shi HJ and Wen JK: miR-146a and Krüppel-like
factor 4 form a feedback loop to participate in vascular smooth
muscle cell proliferation. EMBO Rep. 12:56–62. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reddy MA, Das S, Zhuo C, Jin W, Wang M,
Lanting L and Natarajan R: Regulation of vascular smooth muscle
cell dysfunction under diabetic conditions by miR-504. Arterioscler
Thromb Vasc Biol. 36:864–873. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang J, Chen L, Ding J, Fan Z, Li S, Wu H,
Zhang J, Yang C, Wang H, Zeng P and Yang J: MicroRNA-24 inhibits
high glucose-induced vascular smooth muscle cell proliferation and
migration by targeting HMGB1. Gene. 586:268–273. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou J, Li YS, Nguyen P, Wang KC, Weiss A,
Kuo YC, Chiu JJ, Shyy JY and Chien S: Regulation of vascular smooth
muscle cell turnover by endothelial cell-secreted microRNA-126:
Role of shear stress. Circ Res. 113:40–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nudelman AS, DiRocco DP, Lambert TJ,
Garelick MG, Le J, Nathanson NM and Storm DR: Neuronal activity
rapidly induces transcription of the CREB-regulated microRNA-132,
in vivo. Hippocampus. 20:492–498. 2010.PubMed/NCBI
|
|
25
|
Zhang S, Liang Z, Sun W and Pei L:
Repeated propofol anesthesia induced downregulation of hippocampal
miR-132 and learning and memory impairment of rats. Brain Res.
1670:156–164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tian H, Hou L, Xiong YM, Huang JX, Zhang
WH, Pan YY and Song XR: miR-132 targeting E2F5 suppresses cell
proliferation, invasion, migration in ovarian cancer cells. Am J
Transl Res. 8:1492–1501. 2016.PubMed/NCBI
|
|
27
|
Xu B, Zhang Y, Du XF, Li J, Zi HX, Bu JW,
Yan Y, Han H and Du JL: Neurons secrete miR-132-containing exosomes
to regulate brain vascular integrity. Cell Res. 27:882–897. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qin B, Liu J, Liu S, Li B and Ren J:
MiR-20b targets AKT3 and modulates vascular endothelial growth
factor-mediated changes in diabetic retinopathy. Acta Biochim
Biophys Sin (Shanghai). 48:732–740. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang J, Chen L, Ding J, Rong H, Dong W and
Li X: High mobility group box-1 induces migration of vascular
smooth muscle cells via TLR4-dependent PI3K/Akt pathway activation.
Mol Biol Rep. 39:3361–3367. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yuan Y, Shen Y, Xue L and Fan H: miR-140
suppresses tumor growth and metastasis of non-small cell lung
cancer by targeting insulin-like growth factor 1 receptor. PLoS
One. 8:e736042013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH,
Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, et al: The putative
tumour suppressor microRNA-124 modulates hepatocellular carcinoma
cell aggressiveness by repressing ROCK2 and EZH2. Gut. 61:278–289.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Torella D, Iaconetti C, Tarallo R, Marino
F, Giurato G, Veneziano C, Aquila I, Scalise M, Mancuso T,
Cianflone E, et al: MicroRNA regulation of the hyper-proliferative
phenotype of vascular smooth muscle cells in diabetes mellitus.
Diabetes. 67:2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Choe N, Kwon JS, Kim JR, Eom GH, Kim Y,
Nam KI, Ahn Y, Kee HJ and Kook H: The microRNA miR-132 targets
Lrrfip1 to block vascular smooth muscle cell proliferation and
neointimal hyperplasia. Atherosclerosis. 229:348–355. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ucar A, Gupta SK, Fiedler J, Erikci E,
Kardasinski M, Batkai S, Dangwal S, Kumarswamy R, Bang C, Holzmann
A, et al: The miRNA-212/132 family regulates both cardiac
hypertrophy and cardiomyocyte autophagy. Nat Commun. 3:10782012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rawal S, Munasinghe PE, Shindikar A,
Paulin J, Cameron V, Manning P, Williams MJ, Jones GT, Bunton R,
Galvin I and Katare R: Down-regulation of proangiogenic
microRNA-126 and microRNA-132 are early modulators of diabetic
cardiac microangiopathy. Cardiovasc Res. 113:90–101. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Katare R, Riu F, Mitchell K, Gubernator M,
Campagnolo P, Cui Y, Fortunato O, Avolio E, Cesselli D, Beltrami
AP, et al: Transplantation of human pericyte progenitor cells
improves the repair of infarcted heart through activation of an
angiogenic program involving micro-RNA-132. Circ Res. 109:894–906.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bijkerk R, de Bruin RG, van Solingen C,
van Gils JM, Duijs JM, van der Veer EP, Rabelink TJ, Humphreys BD
and van Zonneveld AJ: Silencing of microRNA-132 reduces renal
fibrosis by selectively inhibiting myofibroblast proliferation.
Kidney Int. 89:1268–1280. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jin W, Reddy MA, Chen Z, Putta S, Lanting
L, Kato M, Park JT, Chandra M, Wang C, Tangirala RK and Natarajan
R: Small RNA sequencing reveals microRNAs that modulate angiotensin
II effects in vascular smooth muscle cells. J Biol Chem.
287:15672–15683. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yerneni KK, Bai W, Khan BV, Medford RM and
Natarajan R: Hyperglycemia-induced activation of nuclear
transcription factor kappaB in vascular smooth muscle cells.
Diabetes. 48:855–864. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen M, Zhang Y, Li W and Yang J:
MicroRNA-145 alleviates high glucose-induced proliferation and
migration of vascular smooth muscle cells through targeting ROCK1.
Biomed Pharmacother. 99:81–86. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
He M, Xue ZM, Li J and Zhou BQ:
Breviscapine inhibits high glucose-induced proliferation and
migration of cultured vascular smooth muscle cells of rats via
suppressing the ERK1/2 MAPK signaling pathway. Acta Pharmacol Sin.
33:606–614. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Anand S, Majeti BK, Acevedo LM, Murphy EA,
Mukthavaram R, Scheppke L, Huang M, Shields DJ, Lindquist JN,
Lapinski PE, et al: MicroRNA-132-mediated loss of p120RasGAP
activates the endothelium to facilitate pathological angiogenesis.
Nat Med. 16:909–914. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu GF, Zhang SH, Li XF, Cao LY, Fu ZZ and
Yu SN: Overexpression of microRNA-132 enhances the radiosensitivity
of cervical cancer cells by down-regulating Bmi-1. Oncotarget.
8:80757–80769. 2017.PubMed/NCBI
|
|
45
|
Chen HZ, Tsai SY and Leone G: Emerging
roles of E2Fs in cancer: An exit from cell cycle control. Nat Rev
Cancer. 9:785–797. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dimova DK and Dyson NJ: The E2F
transcriptional network: Old acquaintances with new faces.
Oncogene. 24:2810–2826. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zheng Y, Zhu C, Ma L, Shao P, Qin C, Li P,
Cao Q, Ju X, Cheng G, Zhu Q, et al: miRNA-154-5p inhibits
proliferation, migration and invasion by targeting E2F5 in prostate
cancer cell lines. Urol Int. 98:102–110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cai C, Huo Q, Wang X, Chen B and Yang Q:
SNHG16 contributes to breast cancer cell migration by competitively
binding miR-98 with E2F5. Biochem Biophys Res Commun. 485:272–278.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chen S, Ding Y, Tao W, Zhang W, Liang T
and Liu C: Naringenin inhibits TNF-alpha induced VSMC proliferation
and migration via induction of HO-1. Food Chem Toxicol.
50:3025–3031. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Portaluppi F, Smolensky MH and Touitou Y:
Ethics and methods for biological rhythm research on animals and
human beings. Chronobiol Int. 27:1911–1929. 2010. View Article : Google Scholar : PubMed/NCBI
|
